Luteal fibroblasts produce prostaglandins in response to IL1β in a MAPK-mediated manner
Molecular and Cellular Endocrinology · 2025
DOI: 10.1016/j.mce.2024.112420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2025. Verfasst von Corrine F Monaco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA; Department of Cellular and Integrative Physiology, Un…. Hauptthemen laut MEDLINE: Interleukin-1beta, Fibroblasts, Prostaglandins, MAP Kinase Signaling System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, BLRD VA, NIA NIH HHS.
Abstract (Originalsprache)
The corpus luteum is a temporary endocrine gland that is crucial for pregnancy, as it produces the progesterone needed to maintain optimal uterine conditions for implantation. In the absence of a conceptus, the corpus luteum becomes non-functional and undergoes rapid tissue remodeling to regress into a fibrotic corpus albicans. Early luteal regression is characterized by increased cytokine release. Because the role of fibroblasts in the bovine corpus luteum remains to be elucidated, the aim of this study was to elucidate the response of bovine luteal fibroblasts to inflammatory cytokines, tumor necrosis factor α (TNFα), and interleukin 1β (IL1β). Both cytokines induced canonical mitogen activated protein kinase (MAPK) signaling in luteal fibroblasts by phosphorylation of ERK1/2, p38 MAPK, and JNK. IL1β elevated expression and phosphorylation of cytosolic phospholipase A2 (cPLA2), an enzyme that mobilizes arachidonic acid for prostanoid synthesis. IL1β also elevated expression of prostaglandin-endoperoxide synthase 2 (PTGS2), another enzyme needed to synthesize prostanoids. IL1β increased PGF2α and PGE2 levels in the culture medium over 20-fold. Inhibition of MAPKs with small-molecule inhibitors abrogated the stimulatory effects of IL1β. IL1β also induced prostaglandin production in steroidogenic cells; however, there was no elevation in cPLA2. Therefore, actions of IL1β differ based on ovarian cell type. All together, we have identified luteal fibroblasts as potential inflammatory mediators during luteal regression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA; Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Animal Science, University of Nebraska-Lincoln, Lincoln, NE, USA.
- Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA; US Department of Veterans Affairs VA Medical Center, Omaha, NE, USA. Electronic address: jsdavis@unmc.edu.
Förderung
- NICHD NIH HHS
- BLRD VA
- NIA NIH HHS
Zitieren
APA
Monaco, C. F., Jones, C. M., Sayles, H. R., Rudloff, B., McFee, R., Cupp, A. S., & Davis, J. S. (2025). Luteal fibroblasts produce prostaglandins in response to IL1β in a MAPK-mediated manner. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112420
Vancouver
Monaco CF, Jones CM, Sayles HR, Rudloff B, McFee R, Cupp AS, et al. Luteal fibroblasts produce prostaglandins in response to IL1β in a MAPK-mediated manner. Molecular and Cellular Endocrinology. 2025. doi:10.1016/j.mce.2024.112420
BibTeX
@article{Monaco2025,
author = {Monaco, Corrine F and Jones, Chloe M and Sayles, Harlan R and Rudloff, Brooke and McFee, Renee and Cupp, Andrea S and Davis, John S},
title = {Luteal fibroblasts produce prostaglandins in response to IL1β in a MAPK-mediated manner},
journal = {Molecular and Cellular Endocrinology},
year = {2025},
doi = {10.1016/j.mce.2024.112420}
}
EUVIMED